Legislative Observatory
European Parliament
Please fill in this field to find a procedure

2005 discharge: European Agency for the Evaluation of Medicinal Products

2006/2161(DEC)

Having examined the revenue and expenditure account for the financial year 2005, the balance sheet of revenue and expenditure at 31 December 2005 of the European Medicines Agency, the Council recommends the European Parliament to give a discharge to the Director of the Agency in respect of the implementation of the budget for the financial year 2005.

In doing so, the Council confirms that EUR 21.6 million (95%) of the EUR 22.7 million in appropriations carried forward from the financial year 2004 to the financial year 2005 have been used. In addition, EUR 18.8 million in appropriations have been carried forward from the financial year 2005 to the financial year 2006 and EUR 5.6 million have been cancelled.

In parallel, the Council makes accompanying comments on the discharge which should be followed up. In particular, it:

  • shares the Court's observation on the high carry-over rate for administrative expenditure in 2004-2005 and calls on the Agency to comply with the principle of annuality;
  • calls on the Agency to respect the rules on the award of contracts, especially as regards IT contracts;
  • shares the Court's opinion on the need to start a new call for tender regarding the services provided by banks and notes from the Agency's reply that this is the case.